FFAFX | TBDZX | FFAFX / TBDZX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 4 years | 7 years | - |
Gain YTD | 21.954 | 24.377 | 90% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 290B | 350M | 82,857% |
Annual Yield % from dividends | 0.70 | 0.00 | - |
Returns for 1 year | 30.54 | 42.68 | 72% |
Returns for 3 years | 1.74 | 3.39 | 51% |
Returns for 5 years | N/A | 54.53 | - |
Returns for 10 years | N/A | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
NQVAX | 54.20 | -0.01 | -0.02% |
Nuveen Multi Cap Value A | |||
EHSTX | 26.31 | -0.05 | -0.19% |
Eaton Vance Large-Cap Value A | |||
TILGX | 28.34 | -0.07 | -0.25% |
Nuveen Large Cap Growth R6 | |||
BNIEX | 10.59 | -0.04 | -0.38% |
UBS International Sustainable Equity A | |||
SBHIX | 25.54 | -0.17 | -0.66% |
Saratoga Health & Biotechnology I |